Agonistic Anti-CD137 Monoclonal Antibody Treatment Induces CD11b+Gr-1+Myeloid-derived Suppressor Cells
Open Access
- 1 January 2010
- journal article
- Published by The Korean Association of Immunobiologists in Immune Network
- Vol. 10 (3), 104-108
- https://doi.org/10.4110/in.2010.10.3.104
Abstract
CD137 (4-1BB/tnfrsf9) has been shown to co-stimulate T cells. However, agonistic anti-CD137 monoclonal antibody (mAb) treatment can suppress CD4+ T cells, ameliorating autoimmune diseases, whereas it induces activation of CD8+ T cells, resulting in diverse therapeutic activity in cancer, viral infection. To investigate the CD137-mediated T cell suppression mechanism, we examined whether anti-CD137 mAb treatment could affect CD11b+Gr-1+ myeloid-derived suppressor cells (MDSCs). Intriguingly, anti-CD137 mAb injection significantly increased CD11b+Gr-1+ cells, peaking at days 5 to 10 and continuing for at least 25 days. Furthermore, this cell population could suppress both CD8+ T cells and CD4+ T cells. Thus, this study demonstrated that, for the first time, anti-CD137 mAb treatment could induce CD11b+Gr-1+ MDSCs under normal conditions, suggesting a possible relationship between myeloid cell induction and CD137-mediated immune suppression.Keywords
This publication has 18 references indexed in Scilit:
- Origins and functional basis of regulatory CD11c+CD8+ T cellsEuropean Journal of Immunology, 2009
- Immune regulation by 4‐1BB and 4‐1BBL: complexities and challengesImmunological Reviews, 2009
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- Identification of regulatory functions for 4-1BB and 4-1BBL in myelopoiesis and the development of dendritic cellsNature Immunology, 2008
- Absence of surface expression of CD137 (4-1BB) on Myeloid-derived suppressor cellsInmunología, 2007
- 4-1BB costimulation enhances HSV-1-specific CD8+ T cell responses by the induction of CD11c+CD8+ T cellsCellular Immunology, 2005
- Stimulation with 4-1BB (CD137) inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor CD4+ T cellsBlood, 2005
- Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistanceImmunology, 2004
- NK and CD8+ T cell‐mediated eradication of poorly immunogenic B16‐F10 melanoma by the combined action of IL‐12 gene therapy and 4‐1BB costimulationInternational Journal of Cancer, 2004
- In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responsesNature Immunology, 2002